Get startedLog in
    Picture of Medicus Pharma logo

    MDCX — Medicus Pharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Medicus Pharma Announces Positively Trending Interim Analysis For SKNJCT-003 Phase 2 Clinical Study

    Picture of Medicus Pharma logoMedicus Pharma
    06/03/2025 12:50
    March 6 (Reuters) - Medicus Pharma Ltd MDCX.O:

MEDICUS PHARMA LTD ANNOUNCES POSITIVELY TRENDING INTERIM ANALYSIS FOR SKNJCT-003 PHASE 2 CLINICAL STUDY TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA OF THE SKIN (BCC)

MEDICUS PHARMA LTD: D-MNA WAS WELL TOLERATED FOR BOTH DOSE LEVELS

MEDICUS PHARMA: PLANS TO SUBMIT ANALYSIS TO FDA UNDER PACKAGE SEEKING TYPE C MEETING WITH FDA IN Q2

Source text: ID:nGNX8f3W0v

Further company coverage: MDCX.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medicus Pharma

    See all news